Instadose Historical Financial Ratios

INSD Stock  USD 0  0.00  0.00%   
Instadose Pharma is lately reporting on over 59 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Free Cash Flow Yield of 0.0 or Average Payables of 5.3 K will help investors to properly organize and evaluate Instadose Pharma Corp financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Instadose Financial Ratios Analysis

Instadose Pharma CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Instadose Pharma investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Instadose financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Instadose Pharma history.

Instadose Pharma Financial Ratios Chart

At present, Instadose Pharma's Average Payables is projected to increase significantly based on the last few years of reporting. The current year's ROIC is expected to grow to 2.73, whereas Book Value Per Share is projected to grow to (0).
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ADividend Yield
Earnings YieldShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Instadose Pharma Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Instadose Pharma sales, a figure that is much harder to manipulate than other Instadose Pharma Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.
Most ratios from Instadose Pharma's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Instadose Pharma Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At present, Instadose Pharma's Average Payables is projected to increase significantly based on the last few years of reporting. The current year's ROIC is expected to grow to 2.73, whereas Book Value Per Share is projected to grow to (0).
 2024 2025 (projected)
Interest Debt Per Share8.54E-47.88E-4
Revenue Per Share4.3E-53.8E-5

Instadose Pharma fundamentals Correlations

0.510.33-0.330.44-0.32-0.410.511.0-0.32-0.310.511.00.280.510.511.00.440.33-0.370.440.510.510.210.510.33
0.510.71-0.710.86-0.71-0.991.00.51-0.71-0.70.990.510.611.01.00.510.860.71-0.880.861.01.00.331.00.68
0.330.71-0.920.9-0.92-0.720.710.33-0.92-0.310.610.330.990.70.70.330.90.92-0.810.90.70.720.80.71.0
-0.33-0.71-0.92-0.921.00.74-0.71-0.331.00.58-0.63-0.32-0.88-0.71-0.71-0.33-0.92-1.00.65-0.92-0.71-0.73-0.88-0.71-0.93
0.440.860.9-0.92-0.92-0.860.860.44-0.92-0.650.80.440.820.860.860.441.00.93-0.771.00.860.870.720.860.89
-0.32-0.71-0.921.0-0.920.74-0.71-0.321.00.57-0.63-0.32-0.88-0.7-0.7-0.32-0.92-1.00.65-0.92-0.7-0.73-0.88-0.7-0.93
-0.41-0.99-0.720.74-0.860.74-0.99-0.410.740.72-0.97-0.41-0.64-0.99-0.99-0.41-0.86-0.750.88-0.86-0.99-0.99-0.37-0.99-0.7
0.511.00.71-0.710.86-0.71-0.990.51-0.71-0.70.990.510.611.01.00.510.860.71-0.880.861.01.00.331.00.68
1.00.510.33-0.330.44-0.32-0.410.51-0.32-0.310.511.00.280.510.511.00.440.33-0.370.440.510.510.210.510.33
-0.32-0.71-0.921.0-0.921.00.74-0.71-0.320.57-0.63-0.32-0.88-0.7-0.7-0.32-0.92-1.00.65-0.92-0.7-0.73-0.88-0.7-0.93
-0.31-0.7-0.310.58-0.650.570.72-0.7-0.310.57-0.75-0.31-0.17-0.72-0.72-0.31-0.65-0.580.31-0.65-0.72-0.71-0.32-0.72-0.31
0.510.990.61-0.630.8-0.63-0.970.990.51-0.63-0.750.510.50.990.990.510.80.64-0.820.80.990.990.240.990.58
1.00.510.33-0.320.44-0.32-0.410.511.0-0.32-0.310.510.280.510.511.00.440.33-0.370.440.510.510.210.510.33
0.280.610.99-0.880.82-0.88-0.640.610.28-0.88-0.170.50.280.60.60.280.820.87-0.790.820.60.630.790.60.99
0.511.00.7-0.710.86-0.7-0.991.00.51-0.7-0.720.990.510.61.00.510.860.71-0.870.861.01.00.331.00.67
0.511.00.7-0.710.86-0.7-0.991.00.51-0.7-0.720.990.510.61.00.510.860.71-0.870.861.01.00.331.00.67
1.00.510.33-0.330.44-0.32-0.410.511.0-0.32-0.310.511.00.280.510.510.440.33-0.370.440.510.510.210.510.33
0.440.860.9-0.921.0-0.92-0.860.860.44-0.92-0.650.80.440.820.860.860.440.93-0.771.00.860.870.720.860.89
0.330.710.92-1.00.93-1.0-0.750.710.33-1.0-0.580.640.330.870.710.710.330.93-0.650.930.710.730.880.710.93
-0.37-0.88-0.810.65-0.770.650.88-0.88-0.370.650.31-0.82-0.37-0.79-0.87-0.87-0.37-0.77-0.65-0.77-0.87-0.88-0.33-0.87-0.79
0.440.860.9-0.921.0-0.92-0.860.860.44-0.92-0.650.80.440.820.860.860.441.00.93-0.770.860.870.720.860.89
0.511.00.7-0.710.86-0.7-0.991.00.51-0.7-0.720.990.510.61.01.00.510.860.71-0.870.861.00.331.00.67
0.511.00.72-0.730.87-0.73-0.991.00.51-0.73-0.710.990.510.631.01.00.510.870.73-0.880.871.00.351.00.7
0.210.330.8-0.880.72-0.88-0.370.330.21-0.88-0.320.240.210.790.330.330.210.720.88-0.330.720.330.350.330.83
0.511.00.7-0.710.86-0.7-0.991.00.51-0.7-0.720.990.510.61.01.00.510.860.71-0.870.861.01.00.330.67
0.330.681.0-0.930.89-0.93-0.70.680.33-0.93-0.310.580.330.990.670.670.330.890.93-0.790.890.670.70.830.67
Click cells to compare fundamentals

Instadose Pharma Account Relationship Matchups

Instadose Pharma fundamentals Accounts

202020212022202320242025 (projected)
Average Payables1.2K908.465.8K5.6K5.0K5.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.01)
Return On Assets
(694.06)
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.